EFCNX
Price
$23.52
Change
+$0.02 (+0.09%)
Updated
Jul 25 closing price
Net Assets
18.19M
RGEBX
Price
$80.73
Change
+$0.27 (+0.34%)
Updated
Jul 25 closing price
Net Assets
328.1B
Interact to see
Advertisement

EFCNX vs RGEBX

Header iconEFCNX vs RGEBX Comparison
Open Charts EFCNX vs RGEBXBanner chart's image
Emerald Insights Investor
Price$23.52
Change+$0.02 (+0.09%)
VolumeN/A
Net Assets18.19M
American Funds Growth Fund of Amer R2E
Price$80.73
Change+$0.27 (+0.34%)
VolumeN/A
Net Assets328.1B
EFCNX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EFCNX vs. RGEBX commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EFCNX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 328B vs. EFCNX (18.2M). EFCNX (0.00) and RGEBX (0.00) have matching dividends . EFCNX was incepted earlier than RGEBX: EFCNX (11 years) vs RGEBX (11 years). EFCNX (2.08) is less costly to investors than RGEBX (1.09). EFCNX is a more actively managed with annual turnover of: 65.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than EFCNX: RGEBX (250) vs EFCNX (2000). EFCNX annual gain was more profitable for investors over the last year : 22.44 vs. RGEBX (16.90). EFCNX return over 5 years is better than : 61.32 vs. RGEBX (45.14).
EFCNXRGEBXEFCNX / RGEBX
Total Expense Ratio1.401.09128%
Annual Report Gross Expense Ratio2.081.09191%
Fund Existence11 years11 years-
Gain YTD12.59013.00497%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets18.2M328B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year22.4416.90133%
Returns for 3 years71.4355.95128%
Returns for 5 years61.3245.14136%
Returns for 10 years108.7078.81138%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLVLY7.750.11
+1.51%
Clinuvel Pharmaceuticals Ltd.
EAATF0.02N/A
N/A
Earthworks Industries Inc.
LABFF90.61N/A
N/A
LABORATORIOS FARMACEUTICOS ROVI SA
FAXXF17.80N/A
N/A
Fairfax Financial Holdings Ltd.
EBKOF91.88-1.76
-1.88%
Erste Group Bank AG